Search Results - "Peddi, V. R."

Refine Results
  1. 1
  2. 2

    Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus by Shihab, F., Qazi, Y., Mulgaonkar, S., McCague, K., Patel, D., Peddi, V. R., Shaffer, D.

    Published in American journal of transplantation (01-09-2017)
    “…A key objective in the use of immunosuppression after kidney transplantation is to attain the optimal balance between efficacy and safety. In a phase 3b,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice by First, M.R., Peddi, V.R., Mannon, R., Knight, R., Marsh, C.L., Kurian, S.M., Rice, J.C., Maluf, D., Mandelbrot, D., Patel, A., David, J., Schieve, C., Lee, D., Lewis, P., Friedewald, J.J., Abecassis, M.M., Rose, S.

    Published in Transplantation proceedings (01-04-2019)
    “…TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients by Peddi, V R, Hariharan, S, Schroeder, T J, First, M R

    Published in Clinical transplantation (01-02-1996)
    “…Neutropenia in solid organ transplant recipients may be caused by immunosuppressive therapy, antimicrobial therapy, as well as bacterial and viral infections…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients by RAM PEDDI, V, BRYANT, Margaret, ROY-CHAUDHURY, Prabir, WOODLE, E. Steve, FIRST, M. Roy

    Published in Transplantation (15-05-2002)
    “…In view of the superior T-cell depletion and prolonged half-life of thymoglobulin, we initiated a protocol to administer thymoglobulin intermittently based on…”
    Get full text
    Journal Article